Skip to main content
SpringerLink
Log in

Serum hormone levels in relation to reproductive and lifestyle factors in postmenopausal women (United States)

  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Objectives: Endogenous sex hormones are thought to be involved in breast and endometrial cancers, but few studies have evaluated the relationships between hormones and risk factors for these diseases. Methods: We related serum hormone and sex-hormone binding globulin (SHBG) levels to reproductive and lifestyle risk factors in a cross-sectional study of 125 postmenopausal women in five geographic regions of the United States. Results: The estrogens were associated positively, while SHBG was associated negatively with body mass index (wt/ht 2). Estrone, (E1), estrone sulfate, and bioavailable estradiol (BioE2) were inversely associated with height. Androstenedione was positively associated with age at menopause, while androstenedione, E1, estradiol, and BioE2 were inversely associated with age at menarche. Weekly alcohol drinkers had higher hormone levels, and lower SHBG levels than those who abstained. Androstenedione and E1 decreased with increasing levels of nonrecreational activity. Conclusions: Several of these findings support the hypothesis that breast and endometrial cancer risk factors are mediated, in part, through increased endogenous hormone levels. The androstenedione findings are of interest in light of studies relating androstenedione to endometrial and possibly breast cancer. An association of age at menarche with E2, independent of androstenedione, may reflect increased aromatase activity in women with earlier menarche.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bernstein L, Ross RK. Endogenous hormones and breast cancer risk. Epidemiol Rev 1993; 15: 48–65.

    Google Scholar 

  2. Brinton LA, Hoover RN. Epidemiology of gynecologic cancers. In: Hoskins WJ, Perez CA, Young RC. Principles and Practice of Gynecologic Oncology. Philadelphia, PA (USA): Lippincott, 1992: 3–26.

    Google Scholar 

  3. Berrino F, Muti P, Micheli A, et al. Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 1996; 88: 291–6.

    Google Scholar 

  4. Dorgan JF, Longcope C, Stephenson HE Jr, et al. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epi Biomark Prev 1996; 5: 533–9.

    Google Scholar 

  5. Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstock GW. A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev 1994; 18: 79–85.

    Google Scholar 

  6. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst 1995; 87: 190–7.

    Google Scholar 

  7. Wysowski DK, Comstock GW, Helsing KJ, Lau HL. Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol 1987; 125: 791–9.

    Google Scholar 

  8. Garland CF, Friedlander NJ, Barrett-Connor E, Khaw KT. Sex hormones and postmenopausal breast cancer: a prospective study in an adult community. Am J Epidemiol 1992; 135: 1220–30.

    Google Scholar 

  9. Potischman N, Hoover RN, Brinton LA, Siiteri P, Dorgan JF, Swanson CA. Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst 1996; 88: 1127–35.

    Google Scholar 

  10. Austin H, Austin JM Jr, Partridge EE, Hatch KD, Shingleton HM. Endometrial cancer, obesity, and body fat distribution. Cancer Res 1991; 51: 568–72.

    Google Scholar 

  11. Ernster VL, Wrensch MR, Petrakis NL, et al. Benign and malignant breast disease: Initial study results of serum and breast fluid analyses of endogenous estrogens. J Natl Cancer Inst 1987; 79: 949–60.

    Google Scholar 

  12. Hankinson SE, Colditz GA, Hunter DJ, et al. Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses' Health Study (United States). Cancer Causes Control 1995; 6: 217–24.

    Google Scholar 

  13. Ingram DM, Nottage EM, Willcox DL, Roberts A. Oestrogen binding and risk factors for cancer. Br J Cancer 1990; 61: 303–7.

    Google Scholar 

  14. Moore JW, Key TJA, Bulbrook RD, et al. Sex hormone binding globulin and risk factors for breast cancer in a population of normal women who had never used exogenous sex hormones. Br J Cancer 1987; 56: 661–6.

    Google Scholar 

  15. Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 1989; 129: 1120–31.

    Google Scholar 

  16. Hankinson SE, Willett WC, Manson JE, et al. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst 1995; 87: 1297–1302.

    Google Scholar 

  17. Lipworth L, Adami HO, Trichopoulos D, Carlström K, Mantzoros C. Serum steroid hormone levels, sex hormonebinding globulin, and body mass index in the etiology of postmenopausal breast cancer. Epidemiology 1996; 7: 96–100.

    Google Scholar 

  18. Frumar AM, Meldrum DR, Geola F, et al. Relationship of fasting urinary calcium to circulating estrogen and body weight in postmenopausalwomen. J Clin Endocrinol Metab 1980; 50: 70–5.

    Google Scholar 

  19. Meldrum DR, Davidson BJ, Tataryn MD, Judd HL. Changes in circulating steroids with aging in postmenopausal women. Obstet Gynecol 1981; 57: 624–8.

    Google Scholar 

  20. Newcomb PA, Klein R, Klein BEK, et al. Association of dietary and life-style factors with sex hormones in postmenopausal women. Epidemiology 1995; 6: 318–21.

    Google Scholar 

  21. Gavaler JS, Love K, VanThiel D, et al. An international study of the relationship between alcohol consumption and postmenopausal estradiol levels. Alcohol Alcohol 1991; (Suppl.) 1: 327–30.

    Google Scholar 

  22. Brinton LA, Hoover RN, and the Endometrial Cancer Collaborative Group. Estrogen replacement therapy and endometrial cancer risk: Unresolved issues. Obstet Gynecol 1993; 82: 265–71.

    Google Scholar 

  23. Sturgeon SR, Brinton LA, Berman ML, et al. Past and present physical activity and endometrial cancer risk. Br J Cancer 1993; 68: 584–9.

    Google Scholar 

  24. Abraham GE, Odell WD, Swerdloff RS, Hopper K. Simultaneous radioimmunoassay of plasma FSH, LH, progesterone, 17-hydroxyprogesterone, and estradiol-17 beta during the menstrual cycle. J Clin Endocrinol Metab 1972; 34: 312–8.

    Google Scholar 

  25. Cassidenti DL, Vijod AG, Vijod MA, Stanczyk FZ, Lobo RA. Short-term effects of smoking on the pharmacokinetic profiles of micronized estradiol in postmenopausalwomen. Am J Obstet Gynecol 1990; 163(6Pt1): 1953–60.

    Google Scholar 

  26. Rosner W. A simplified method for the quantitative determination of testosterone concentration, an index of androgenicity. J Clin Endocrinol Metab 1971; 33: 759–67.

    Google Scholar 

  27. Vermeulen A. The hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metab 1976; 42: 247–53.

    Google Scholar 

  28. SASInstitute. SAS/Stat User's Guide, Volume 1 and 2, Version 6. Cary, NC (USA): SAS Institute Inc., 1989.

    Google Scholar 

  29. Bruning PF, Bonfrer JMG, Hart AAM, et al. Body measurements, estrogen availability and the risk of human breast cancer: A case-control study. Int J Cancer 1992; 51: 14–9.

    Google Scholar 

  30. Pasquali R, Vicennati V, Bertazzo D, et al. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Metabolism 1997; 46: 5–9.

    Google Scholar 

  31. Hunter DJ, Willett WC. Diet, body size, and breast cancer. Epidemiol Rev 1993; 15: 110–32.

    Google Scholar 

  32. Trichopoulos D, Brown J, MacMahon B. Urine estrogens and breast cancer risk factors among post-menopausal women. Int J Cancer 1987; 40: 721–5.

    Google Scholar 

  33. Armstrong BK, Brown JB, Clarke HT, et al. Diet and reproductive hormones: A study of vegetarian and nonvegetarian postmenopausal women. J Natl Cancer Inst 1981; 67: 761–7.

    Google Scholar 

  34. Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr 1987; 45: 277–82.

    Google Scholar 

  35. Vermeulen A, Verdonck L. Factors affecting sex hormone levels in postmenopausal women. J Steroid Biochem 1979; 11: 899–904.

    Google Scholar 

  36. Chakravarti S, Collins WP, Forecast JD, Newton JR, Oram DH, Studd JWW. Hormonal profiles after the menopause. Br Med J 1976; 2: 784–6.

    Google Scholar 

  37. Crilly RG, Marshall DH, Nordin BEC.Adrenal androgens in post-menopausal osteoporosis. In: Genazzani AR, ed. Adrenal Androgens. New York, NY (USA): Raven Press, 1980: 241–58.

    Google Scholar 

  38. Roger M, Nahoul K, Scholler R, Bagrel D. Evolution with ageing of four plasma androgens in postmenopausal women. Maturitas 1980: 2: 171–7.

    Google Scholar 

  39. Vermeulen A, Verdonck L. Sex hormone concentrations in post-menopausal women. Clin Endocrinol 1978; 9: 59–66.

    Google Scholar 

  40. Crilly RG, Marshall DH, Nordin BEC. Effect of age on plasma androstenedione concentration in oophorectomized women. Clin Endocrinol 1979; 10: 199–201.

    Google Scholar 

  41. Kirchengast S. Sex hormone concentrations and body dimensions of postmenopausal women as correlates of age at menarche. Anthropol Anz 1993; 51: 251–65.

    Google Scholar 

  42. Apter D, Reinila M, Vihko R. Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood. Int J Cancer 1989; 44: 783–7.

    Google Scholar 

  43. MacMahon B, Trichopoulos D, Brown J et al. Age at menarche, urine estrogens and breast cancer risk. Int J Cancer 1982; 30: 427–1.

    Google Scholar 

  44. Moore JW, Key TJA, Wang DY, Bulbrook RD, Hayward JL, Takatani O. Blood concentrations of estradiol and sex hormone-binding globulin in relation to age at menarche in premenopausal British and Japanesewomen. Breast Cancer Res Treat 1991; 18: 547–50.

    Google Scholar 

  45. Bernstein L, Pike MC, Ross RK, Henderson BE. Age at menarche and estrogen concentrations of adult women. Cancer Causes Control 1991; 2: 221–5.

    Google Scholar 

  46. Dorgan JF, Reichman ME, Judd JT, et al. Relationships of age and reproductive characteristics with plasma estrogens and androgens in premenopausal women. Cancer Epi Biomark Prev 1996; 4: 381–6.

    Google Scholar 

  47. Westhoff C, Gentile G, Lee J, Zacur H, Helbig D. Predictors of ovarian steroid secretion in reproductive-age women. Am J Epidemiol 1996; 144: 381–8.

    Google Scholar 

  48. Katsouyanni K, Boyle P, Trichopoulos D. Diet and urine estrogens among postmenopausal women. Oncology 1991; 48: 490–4.

    Google Scholar 

  49. Baron JA, LaVecchia C, Levi F. The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol 1990; 162: 502–14.

    Google Scholar 

  50. Ruiz E, Osorio E, Ortega E. Androgenic status in cyclic and postmenopausalwomen:Acomparison between smokers and nonsmokers. Biochem Int 1992; 27: 841–5.

    Google Scholar 

  51. Austin H, Drews C, Partridge EE. A case-control study of endometrial cancer in relation to cigarette smoking, serum estrogen levels, and alcohol use.AmJ ObstetGynecol 1993; 169: 1086–91.

    Google Scholar 

  52. Khaw KT, Tazuke S, Barrett-Connor E. Cigarette smoking and levels of adrenal androgens in postmenopausal women. N Engl J Med 1988; 318: 1705–9.

    Google Scholar 

  53. Longcope C, Johnston CC Jr. Androgen and estrogen dynamics in pre-and postmenopausal women: A comparison between smokers and nonsmokers. J Clin Endocrinol Metab 1988; 67: 379–83.

    Google Scholar 

  54. Friedman AJ, Ravnikar VA, Barbieri RL. Serum steroid hormone profiles in postmenopausal smokers and nonsmokers. Fertil Steril 1987; 47: 398–401.

    Google Scholar 

  55. Jensen J, Christiansen C. Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy. Am J Obstet Gynecol 1988; 159: 820–5.

    Google Scholar 

  56. Key TJA, Chen J, Wang DY, Pike MC, Boreham J. Sex hormones in women in rural China and in Britain. Br J Cancer 1990; 62: 631–6.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Epidemiology & Biostatistics Program, Division of Cancer Epidemiology & Genetics, National Cancer Institute, Bethesda, USA

    M. Patricia Madigan, Rebecca Troisi, Nancy Potischman, Joanne F. Dorgan, Louise A. Brinton & Robert N. Hoover

Authors
  1. M. Patricia Madigan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rebecca Troisi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nancy Potischman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joanne F. Dorgan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Louise A. Brinton
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Robert N. Hoover
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Madigan, M.P., Troisi, R., Potischman, N. et al. Serum hormone levels in relation to reproductive and lifestyle factors in postmenopausal women (United States). Cancer Causes Control 9, 199–207 (1998). https://doi.org/10.1023/A:1008838412423

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1008838412423

Search

Navigation